IgA nephropathy, stem cell treatments among top nephrology news of 2023

Healio has compiled a list of its most-read nephrology care news in 2023.
Readers were most interested in proteinuria and GFR results with a new IgA nephropathy drug, stem cell transplantation to protect donor kidneys and remarks from the former HHS Secretary on value-based care for end-stage kidney disease.
Results from a phase 2 trial of a new drug to treat IgA nephropathy showed a reduction in proteinuria and stabilization of eGFR vs. controls after 36 weeks, according to a presentation at the European Renal Association Congress. Read more.
Transplantation of stem cells prior to the patient

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart